Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Palisade Bio Inc PALI

Healthcare Biotechnology
Palisade Bio, Inc. is a biopharmaceutical company focused on developing novel therapeutics for serious chronic gastrointestinal diseases. It is engaged in advancing a PALI-2108 for the treatment of IBD, including UC and CD and are researching PALI-1908. IBD is a chronic condition characterized by inflammation within the gastrointestinal tract. UC primarily affects the colon and the rectum. CD... see more

Recent & Breaking News (NDAQ:PALI)

Wall Street Fundamentals Releases New In-Depth Stock Reports on ACAD, CUR, INO and PIP

Accesswire September 10, 2013

InvestorsGuru.com 32 Filtered Mid-Day Market Movers Recap

Investors Guru September 7, 2013

Neuralstem To Raise $4 Million In Registered Direct Offering

PR Newswire September 5, 2013

Neuralstem President And CEO To Present At The 2013 Rodman & Renshaw Annual Healthcare Conference

PR Newswire September 3, 2013

Neuralstem Reports Second Quarter Financial Results And Provides Business And Clinical Update

PR Newswire August 9, 2013

Neuralstem, Inc. President and CEO Publishes New Blog Entitled "How far that little candle throws his beams! So shines a good deed in a weary world"

Accesswire August 7, 2013

Neuralstem Cells Reverse Cognitive Defect In Brain-Irradiated Rats, University Of California Irvine Paper Shows

PR Newswire August 1, 2013

Arch Therapeutics (ARCH) Targets Hemostasis Division of Growing $52 Billion In-Vitro Diagnostics Market

Marketwired June 24, 2013

President and CEO Publishes New Blog Entitled ''Progress!''

Accesswire June 19, 2013

Fat Cells Lending to New Treatments in Brain Cancer

Accesswire June 13, 2013

Neuralstem ALS Trial Principal Investigator, Dr Eva Feldman, Gives Grand Plenary Address At The Canadian Neurological Sciences Federation Annual Congress

Canada NewsWire June 10, 2013

Neuralstem ALS Trial Principal Investigator, Dr Eva Feldman, Gives Grand Plenary Address At The Canadian Neurological Sciences Federation Annual Congress

PR Newswire June 10, 2013

Neuralstem's Cells Induce Improvement In Acute Spinal Cord Injury Rats, UCSD Study Shows

PR Newswire May 28, 2013

Neuralstem Inc. President and CEO Publishes New Blog Entitled ''O brave new world...''

Accesswire May 22, 2013

Neuralstem ALS Trial Principal Investigator, Dr. Eva Feldman, Presented Phase I Data At The Neuro Diabetes Medical Symposium In Romania

PR Newswire May 20, 2013

InvestorsGuru.com 31 Filtered Mid-Day Market Movers Recap

Investors Guru May 19, 2013

Neuralstem CEO, Richard Garr, To Present At Annual World Stem Cells And Regenerative Medicine Congress In London

PR Newswire May 16, 2013

Neuralstem Principal Investigator, Dr. Eva Feldman, Presents Phase I ALS Trial Data At The Romanian Neurological Society Congress

PR Newswire May 13, 2013

InvestorsGuru.com 42 Filtered Mid-Day Market Movers Recap

Investors Guru May 12, 2013

Neuralstem Reports First Quarter Financial Results And Provides Business And Clinical Update

PR Newswire May 10, 2013